167027-30-7

Basic information

• Product Name: METHYL 6-AMINO-1H-INDOLE-2-CARBOXYLATE
• Synonyms: METHYL 6-AMINO-1H-INDOLE-2-CARBOXYLATE;1H-Indole-2-carboxylicacid,6-amino-,methylester(9CI);6-Amino-1H-indole-2-carboxylic acid methyl ester
• CAS NO: 167027-30-7
• Molecular Formula: C₁₀H₁₀N₂O₂
• Molecular Weight: 190.2
• Product Categories: AMINOACID
• Mol File: 167027-30-7.mol

Chemical Properties

• Boiling Point: 415.407 °C at 760 mmHg
• Flash Point: 205.031 °C
• Appearance: /
• Density: 1.339 g/cm³
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: 16.20±0.30(Predicted)
• CAS DataBase Reference: METHYL 6-AMINO-1H-INDOLE-2-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 6-AMINO-1H-INDOLE-2-CARBOXYLATE(167027-30-7)
• EPA Substance Registry System: METHYL 6-AMINO-1H-INDOLE-2-CARBOXYLATE(167027-30-7)

Safety Data

• Hazardous Substances Data: 167027-30-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research and Development:
METHYL 6-AMINO-1H-INDOLE-2-CARBOXYLATE is used as a building block in the synthesis of new drugs and pharmaceuticals for its ability to contribute to the creation of bioactive molecules and pharmaceutical intermediates.
Used in Medicinal Chemistry:
METHYL 6-AMINO-1H-INDOLE-2-CARBOXYLATE is used as a precursor for the development of compounds with potential therapeutic applications, leveraging its structural properties to enhance drug efficacy and target specificity.
Used in Antibacterial Applications:
METHYL 6-AMINO-1H-INDOLE-2-CARBOXYLATE is studied for its potential as an antibacterial agent, indicating its use in combating bacterial infections due to its demonstrated biological activities.
Used in Antiviral Applications:
METHYL 6-AMINO-1H-INDOLE-2-CARBOXYLATE is also being investigated for its antiviral properties, suggesting its use in the development of treatments for viral diseases.

Upstream product

• 428861-43-2 methyl 6-nitroindoline-2-carboxylate 
• 428861-42-1 6-nitroindoline-2-carboxylic acid 
• 16851-56-2 indolin-2-yl carboxylic acid 
• 1427164-16-6 6-acetamidoindole-2-carboxylic acid methyl ester 
• 122-85-0 para-acetamidobenzaldehyde 
• 1049677-82-8 1-(tert-butyl) 2-methyl 6-amino-1H-indole-1,2-dicarboxylate 
• 1093261-18-7 1-(1,1-dimethylethyl) 2-methyl 6-nitro-1H-indole-1,2-dicarboxylate 
• 10242-00-9 6-Nitro-1H-indole-2-carboxylic Acid 
• 136818-66-1 6-Nitro-1H-indole-2-carboxylic acid methyl ester 
• 541522-65-0 methyl 6-({[(1,1-dimethylethyl)oxy]carbonyl}amino)-1H-indole-2-carboxylate 

Downstream Products

• 1093255-84-5 6-amino-N-({4-chloro-3-[(3-chloro-5-cyanophenyl)oxy]-2-fluorophenyl}methyl)-1H-indole-2-carboxamide trifluoroacetate 
• 1093261-27-8 6-({[(1,1-dimethylethyl)oxy]carbonyl}amino)-1H-indole-2-carboxylic acid 
• 541522-65-0 methyl 6-({[(1,1-dimethylethyl)oxy]carbonyl}amino)-1H-indole-2-carboxylate 

Relevant articles and documents

5-SULFAMOYL-2-HYDROXYBENZAMIDE DERIVATIVES

The invention is directed to substituted salicylamide derivatives. Specifically, the invention is directed to compounds according to Formula (I): wherein R, R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof. The compounds of the invention are inhibitors of CD73 and can be useful in the treatment of cancer, pre-cancerous syndromes and diseases associated with CD73 inhibition, such as AIDS, the treatment of HIV, autoimmune diseases, infections, atherosclerosis, and ischemia–reperfusion injury. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting CD73 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

Substituted benzene and heterocyclic compound and its preparation method and application

The invention provides substituted benzoheterocyclic compounds and a preparation method thereof. The compounds have structures shown by formulas I and II. The invention also provides the effects of the compounds shown by formulas I and II in resisting virus, tumor and the like. The invention further provides a medicine composition taking the compounds shown by the formulas I and II as active ingredients, and the anti-virus or anti-tumor effect of the medicine composition. The invention lays a foundation for the future in-depth study and development of the anti-virus or anti-tumor medicine of the compounds.

HETEROCYCLIC DERIVATIVES AND USE THEREOF

A heterocyclic derivative represented by formula (I), or a pharmaceutically acceptable salt or a stereoisomer thereof, which has an inhibitory effect on the activation of STAT3 protein, and is useful for the prevention or treatment of diseases associated with the activation of STAT3 protein.

Design, synthesis and antiproliferative activity of a novel class of indole-2-carboxylate derivatives

Based on the chemical structure of Pyrroloquinoline quinone (PQQ), a novel class of indole-2-carboxylate derivatives was designed, synthesized and assayed for antiproliferative activity in cancer cells in vitro. The biological results showed that some der

CHEMICAL COMPOUNDS

The present invention relates to compounds that are a non-nucleoside reverse transcriptase inhibitors, and to processes for the preparation and use of the same. Specifically, the present invention includes methods of using such compounds in the treatment of human immunodeficiency virus infection.

Novel aromatic compounds possessing antifungal or antibacterial activity

The present invention provides novel compounds possessing antibacterial, antifungal, antiviral, anticancer, and/or antiparasitic activities. Pharmaceutical compositions containing these compounds, methods of making and methods for using these compounds ar

Indole nitriles

Compounds of the formula (I) wherein m, n, R1, R2, R3, R4, R5 and R6 are as described herein, together with methods for making the compounds and using the compounds for treatment of diseases or conditions mediated by Cathepsin K.